Disruptive Behavior Disorder Treatment Global Market Report 2025

The disruptive behavior disorder treatment market size has grown strongly in recent years. It will grow from $1.52 billion in 2024 to $1.62 billion in 2025 at a compound annual growth rate (CAGR) of 6.1%. The growth during the historic period can be attributed to the increasing incidence of drug abuse, a higher prevalence of mental disorders among children, a growing consumer preference for online shopping, improved diagnosis rates, and a rise in cases of oppositional defiant disorder.

The disruptive behavior disorder treatment market size is expected to see strong growth in the next few years. It will grow to $2.03 billion in 2029 at a compound annual growth rate (CAGR) of 5.9%. The projected growth in the forecast period can be attributed to the increasing prevalence of disruptive behavior disorders, heightened awareness and improved diagnosis rates, expanding government initiatives, rising demand for healthcare services, and a growing number of awareness campaigns. Key trends expected during this period include the adoption of digital therapeutics, the rise of telepsychiatry platforms, the use of wearable mental health devices, mobile health applications, virtual reality-based therapy, remote tools for parent training, and the application of machine learning in diagnosis.

The rising prevalence of mental illness is anticipated to drive the growth of the disruptive behavior disorder treatment market in the coming years. Mental illness encompasses a broad range of mental health conditions that impact an individual’s mood, thoughts, behavior, and overall functioning. This growing prevalence is largely attributed to increasing levels of chronic stress, which can impair brain function and contribute to the onset or worsening of mental health disorders. Disruptive behavior disorder treatment supports mental illness management by targeting persistent behavioral problems in children and adolescents, making early intervention crucial. These treatments improve emotional regulation and social interaction through specialized therapies, leading to better mental health outcomes. For example, in 2022, the National Institute of Mental Health - a U.S.-based federal research agency - reported that 59.3 million adults aged 18 and over in the United States experienced any mental illness (AMI), representing 23.1% of the adult population. Thus, the growing prevalence of mental illness is fueling the expansion of the disruptive behavior disorder treatment market.

The increasing healthcare expenditure is expected to drive the growth of the disruptive behavior disorder treatment market in the coming years. Healthcare expenditure refers to the total financial resources allocated toward medical services, treatments, healthcare facilities, research, and public health efforts aimed at improving or maintaining health outcomes. This rise in expenditure is largely driven by an aging population that demands more medical attention, treatments, and long-term healthcare services. Higher healthcare spending enhances the delivery of disruptive behavior disorder treatments by improving access to specialized therapies, medications, and early intervention programs. It also facilitates the development of advanced treatment models, leading to better mental health outcomes and higher standards of care. For example, in December 2024, the Centers for Medicare & Medicaid Services (CMS) - a U.S.-based federal agency - reported that national health expenditures (NHE) increased by 7.5% to $4.9 trillion in 2023, making up 17.6% of the gross domestic product (GDP). Hence, the rise in healthcare expenditure is contributing to the growth of the disruptive behavior disorder treatment market.

The growing use of telehealth services is expected to drive the expansion of the disruptive behavior disorder treatment market in the coming years. Telehealth services involve delivering healthcare remotely through phones, video conferencing, or mobile applications, enabling patients to consult with medical professionals without visiting a physical clinic or hospital. The increasing adoption of telehealth is fueled by the convenience it offers, particularly in managing chronic conditions from the comfort of home. In the context of disruptive behavior disorder treatment, telehealth improves access to therapy and counseling by providing remote care options, especially for individuals in rural or underserved areas. It helps eliminate treatment barriers through flexible scheduling and real-time support, leading to better treatment adherence and improved mental health outcomes. For example, in February 2023, a survey conducted by Rock Health - a U.S.-based digital health innovation company - of 8,014 respondents from July to August 2022 revealed that 80% had used telemedicine at least once in 2022, up from 72% in 2021. Thus, the increasing prevalence of telehealth services is contributing to the growth of the disruptive behavior disorder treatment market.

Major players in the disruptive behavior disorder treatment market are Pfizer Inc., Johnson & Johnson, AbbVie Inc., Novartis AG, GSK plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd, Otsuka Pharmaceutical Co. Ltd., Nationwide Children’s Hospital, Seattle Children’s Hospital, Children’s Hospital of Philadelphia, Hikma Pharmaceuticals, Boston Children’s Hospital, Children’s Hospital of Wisconsin, Stanford Medicine Children’s Health, Children’s Hospital New Orleans, Sunovion Pharmaceuticals Inc., Piney Ridge Treatment Center, Village Behavioral Health.

North America was the largest region in the disruptive behavior disorder treatment market in 2024. The regions covered in disruptive behavior disorder treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the disruptive behavior disorder treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Disruptive behavior disorder (DBD) treatment encompasses a variety of therapeutic methods designed to manage and alleviate the symptoms associated with conditions such as Oppositional Defiant Disorder (ODD) and Conduct Disorder (CD). The primary objective of DBD treatments is to enhance a child’s behavior, emotional self-regulation, and ability to interact socially.

The primary categories of disruptive behavior disorder treatment include oppositional defiant disorder, conduct disorder, and intermittent explosive disorder. Oppositional defiant disorder is a behavioral issue characterized by ongoing patterns of defiant, hostile, and uncooperative behavior in children or adolescents, particularly toward authority figures. Treatment strategies consist of medication management, thorough evaluations, family therapy, parenting interventions, group therapy, individual therapy, and training in social and emotional skills. These approaches are tailored for various age groups, including children aged 4 to 12, adolescents aged 13 to 17, young adults aged 18 to 24, and adults aged 25 and older. Key service providers include hospitals, outpatient clinics, residential treatment centers, home care environments, and dedicated disruptive behavior disorder treatment facilities.

The disruptive behavior disorder treatment market research report is one of a series of new reports that provides disruptive behavior disorder treatment market statistics, including disruptive behavior disorder treatment industry global market size, regional shares, competitors with a disruptive behavior disorder treatment market share, detailed disruptive behavior disorder treatment market segments, market trends and opportunities, and any further data you may need to thrive in the disruptive behavior disorder treatment industry. This disruptive behavior disorder treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The disruptive behavior disorder treatment market consists of revenues earned by entities by providing services such as behavioral therapy, parent management training, counseling, social skills development programs, psychiatric evaluations, medication management, and support for families and schools. The market value includes the value of related goods sold by the service provider or included within the service offering. The disruptive behavior disorders treatment market also includes sales of therapeutic tools, digital mental health apps, assessment kits, and educational materials designed to support diagnosis and treatment. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.